Graphical '/> Self-nanoemulsifying drug delivery systems of myricetin: Formulation development, characterization, and <ce:italic>in vitro</ce:italic> and <ce:italic>in vivo</ce:italic> evaluation
首页> 外文期刊>Colloids and Surfaces, B. Biointerfaces >Self-nanoemulsifying drug delivery systems of myricetin: Formulation development, characterization, and in vitro and in vivo evaluation
【24h】

Self-nanoemulsifying drug delivery systems of myricetin: Formulation development, characterization, and in vitro and in vivo evaluation

机译:自我乳胶化药物递送系统Myricetin:配方发育,表征和体外>斜体>和在体内评估

获取原文
获取原文并翻译 | 示例
           

摘要

Graphical abstractDisplay OmittedHighlights?Four Myr-SNEDDS with different characteristics were successfully prepared and evaluated.?The components and ratios of each component had influence on the properties of each SNEDDS formulation.?Myr-SNEDDS can improve the solubility and permeability of Myr.?The SNEDDS can improve the bioavailability of insoluble herbal drugs like Myr.AbstractDespite various pharmacological effects, myricetin (Myr) shows low oral bioavailability (<10%) due to its poor solubility, which limits its applications. To address this problem, self-nanoemulsifying drug delivery systems
机译:<![cdata [ 图形抽象 显示省略 突出显示 成功准备和评估了四种具有不同特征的MYR-SNEDDS。 每个组件的组件和比率有inf关于每个SNEDDS配方的性质的借鉴。 Myr-Snedds可以提高MYR的溶解度和渗透率。 snedds可以提高不溶性草药药物的生物利用度,如myr。 抽象 尽管各种药理学效果,Myricetin(MYR)由于其溶解度差而显示出低口服生物利用度(<10%),这限制了其应用。为了解决这个问题,自我乳化药物递送系统

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号